MICROBIAL PATHOGENESIS

Scope & Guideline

Driving Insights into Microbial Disease Dynamics

Introduction

Immerse yourself in the scholarly insights of MICROBIAL PATHOGENESIS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0882-4010
PublisherACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1986 to 2024
AbbreviationMICROB PATHOGENESIS / Microb. Pathog.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address24-28 OVAL RD, LONDON NW1 7DX, ENGLAND

Aims and Scopes

MICROBIAL PATHOGENESIS focuses on the complex interactions between microbes and their hosts, emphasizing the mechanisms of pathogenesis, host response, and the development of novel therapeutic strategies. The journal aims to publish high-quality research that advances our understanding of microbial diseases and explores innovative approaches for prevention and treatment.
  1. Microbial Pathogenesis Mechanisms:
    Research exploring the molecular and cellular mechanisms by which pathogens cause disease, including the study of virulence factors and host-pathogen interactions.
  2. Antimicrobial Resistance:
    Investigations into the mechanisms of resistance in various microbial species, including bacteria, fungi, and viruses, alongside strategies to combat resistance.
  3. Therapeutic Innovations:
    Development and evaluation of new therapeutic strategies, including vaccines, antimicrobial peptides, and phage therapy, aimed at treating infections caused by pathogenic microbes.
  4. Microbiome Research:
    Studies focusing on the role of the microbiome in health and disease, particularly how gut and environmental microbiota interact with pathogens and influence disease outcomes.
  5. Zoonotic Diseases:
    Research addressing the transmission and pathology of diseases that can be transmitted from animals to humans, emphasizing the importance of understanding these interactions for public health.
  6. Infectious Disease Epidemiology:
    Epidemiological studies aimed at understanding the prevalence, risk factors, and transmission dynamics of infectious diseases, particularly in specific populations.
The journal has embraced several emerging themes that reflect current trends in microbial research. These themes highlight the journal's commitment to addressing contemporary challenges in microbial pathogenesis and therapeutics.
  1. Environmental Microbiology:
    There is an increasing interest in the role of environmental factors and microbiota in disease processes, particularly in the context of climate change and its impact on microbial behavior.
  2. Host-Microbiome Interactions:
    Research focusing on the intricate relationships between the host's immune system and its microbiota is gaining traction, showcasing how these interactions can influence disease outcomes.
  3. Vaccine Development:
    A notable trend is the focus on innovative vaccine strategies, including multi-epitope vaccines and the use of adjuvants, reflecting the urgent need for effective vaccines against emerging infectious diseases.
  4. Nanotechnology in Microbial Control:
    The application of nanotechnology for developing new antimicrobial agents and delivery systems is on the rise, providing novel ways to combat drug-resistant pathogens.
  5. Immunotherapy:
    Emerging studies are exploring the potential of immunotherapies, including the use of monoclonal antibodies and immune modulators, in treating infectious diseases and their complications.

Declining or Waning

While the journal continues to thrive in many areas, certain themes have seen a decline in focus over recent years. This may reflect shifts in research priorities or the emergence of new, more pressing topics within the field.
  1. Traditional Antibiotics:
    There has been a noticeable decline in studies solely focused on conventional antibiotics, as researchers shift towards exploring alternative therapies like phage therapy and antimicrobial peptides.
  2. Single Pathogen Studies:
    Research focusing exclusively on individual pathogens without considering their interactions within the microbiome or with host systems is waning, as there is a growing recognition of the complexity of microbial ecosystems.
  3. Basic Pathogen Characterization:
    The focus on basic characterization of pathogens, such as morphology and biochemical properties, is decreasing in favor of more integrative approaches that include genomic and proteomic analyses.

Similar Journals

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

Fostering collaboration in infectious disease research.
Publisher: AKADEMIAI KIADO ZRTISSN: 1217-8950Frequency: 4 issues/year

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.

MIKROBIYOLOJI BULTENI

Illuminating the Pathways of Microbial Research
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Emerging Microbes & Infections

Connecting researchers to combat emerging microbes.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.

BRAZILIAN JOURNAL OF MICROBIOLOGY

Advancing Microbial Knowledge Globally
Publisher: SPRINGERISSN: 1517-8382Frequency: 4 issues/year

The BRAZILIAN JOURNAL OF MICROBIOLOGY, published by SPRINGER, stands as a pivotal platform in the field of microbiology, offering an open access model since 2000. With the ISSN 1517-8382 and E-ISSN 1678-4405, this esteemed journal encourages the dissemination of groundbreaking research and innovative methodologies that contribute to the understanding of microbial life, its role in health and disease, and its environmental impact. Based in Switzerland and accessible globally, the journal’s categorization in the Q3 quartile for Microbiology reflects its commitment to quality and relevance in the scientific community. As of 2023, it ranks 121 out of 182 in the Scopus listings for Microbiology, further highlighting its growing influence in immunology and microbiological research. With converged years spanning from 1992 to 2024, the journal continues to support a diverse range of studies, making it an invaluable resource for researchers, professionals, and students alike.

Jundishapur Journal of Microbiology

Empowering scientists to unravel the mysteries of microbiology.
Publisher: BRIEFLANDISSN: 2008-3645Frequency: 12 issues/year

Welcome to the Jundishapur Journal of Microbiology, a peer-reviewed publication dedicated to advancing the field of microbiology. Published by BRIEFLAND, this journal focuses on key areas such as infectious diseases and medical microbiology, offering a platform for researchers to share their findings from 2009 to 2024. Despite its current positioning in Quartile 4 across various categories in 2023, the journal provides a valuable resource for budding scientists and established professionals alike, contributing to the growing body of knowledge in these critical areas. While it is not an open-access journal, the Jundishapur Journal prioritizes the dissemination of research in the Netherlands, facilitating a deeper understanding of microbial science and its implications for public health. Join a community of innovators committed to exploring both emerging and established themes in microbiology.

mSphere

Unleashing the power of molecular exploration.
Publisher: AMER SOC MICROBIOLOGYISSN: Frequency: 6 issues/year

mSphere is a leading open-access journal published by the American Society for Microbiology, dedicated to the dynamic fields of Microbiology and Molecular Biology. Since its inception in 2016, mSphere has rapidly established itself as a reputable source of scholarly research, achieving notable impact factors and excellence within the academic community. The journal ranks in the top quartile (Q1) amongst its peers in Microbiology, and Q2 in the field of Molecular Biology, demonstrating its significance and relevance through Scopus rankings—specifically, it holds the #42 spot out of 182 in the Microbiology category and #108 out of 410 in Molecular Biology. With an editorial commitment to advancing the understanding of microbial and molecular sciences, mSphere provides an accessible platform for researchers, professionals, and students alike to disseminate groundbreaking findings. The journal promotes rigorous peer-review and invites innovative contributions aimed at enhancing microbial research mobility and molecular exploration. Accessible openly since 2016, mSphere continues to thrive as an influential publication driving scientific dialogue and discovery in the microbiological sciences.

Future Microbiology

Advancing the Frontiers of Microbial Science
Publisher: FUTURE MEDICINE LTDISSN: 1746-0913Frequency: 18 issues/year

Future Microbiology is a leading journal in the field of microbiology, published by FUTURE MEDICINE LTD in the United Kingdom. Since its inception in 2006, it has aimed to provide a comprehensive forum for the advancement of knowledge in microbiological research, particularly within the medical domain. With its current impact factor classifications placing it in Q3 for general microbiology and Q2 for medical microbiology as of 2023, it has established itself as a significant contributor to scientific discourse. The journal, featuring ISSN 1746-0913 and E-ISSN 1746-0921, actively engages researchers, professionals, and students, presenting them with novel insights and findings that enhance our understanding of microbial science. The publication is designed not only to showcase innovative research but also to foster collaborations and discussions across disciplines. While currently not offering open access, Future Microbiology remains committed to disseminating high-quality content that informs and inspires the ongoing exploration of microbiology and its critical role in healthcare.

European Journal of Microbiology and Immunology

Pioneering Research for a Healthier Tomorrow
Publisher: AKADEMIAI KIADO ZRTISSN: 2062-8633Frequency: 4 issues/year

Welcome to the European Journal of Microbiology and Immunology, a premier platform dedicated to advancing the field of microbiology and immunology through the dissemination of high-quality research. Published by AKADEMIAI KIADO ZRT in Hungary, this journal serves as an essential resource for researchers, professionals, and students alike, fostering scholarly communication and innovation in these critical areas of medical science. The journal, which holds an ISSN of 2062-8633, presents rigorously peer-reviewed articles that contribute to our understanding of microbial diseases, immune responses, and related fields, currently ranking in the Q2 and Q3 quartiles across multiple categories such as immunology and microbiology. By embracing an inclusive scholarly dialogue and offering a robust readership, the European Journal of Microbiology and Immunology aims to inspire the next wave of discoveries and collaborations within the global scientific community.

TRENDS IN MICROBIOLOGY

Innovating Insights in Microbiology and Pathogen Biology
Publisher: CELL PRESSISSN: 0966-842XFrequency: 12 issues/year

TRENDS IN MICROBIOLOGY is a premier academic journal published by CELL PRESS, renowned for its high-impact research contributions in the fields of microbiology, infectious diseases, medical microbiology, and virology. With an impressive impact factor and a notable Scopus ranking—placing it in the top tiers of its categories, including a remarkable Q1 status in multiple disciplines—this journal is essential for researchers, professionals, and students aiming to stay at the forefront of innovative microbial research and ongoing advancements in pathogen biology. Since its inception in 1993, TRENDS IN MICROBIOLOGY has provided a platform for thought-provoking reviews and critical insights, fostering discussions that shape the future of the microbiological sciences. Based in the United Kingdom, TRENDS IN MICROBIOLOGY continues to lead the way in disseminating vital knowledge within the global scientific community.

REVISTA ARGENTINA DE MICROBIOLOGIA

Championing the dissemination of vital microbiological discoveries.
Publisher: ASOCIACION ARGENTINA MICROBIOLOGIAISSN: 0325-7541Frequency: 4 issues/year

REVISTA ARGENTINA DE MICROBIOLOGIA, published by the ASOCIACION ARGENTINA MICROBIOLOGIA, stands as a prominent open-access journal in the field of microbiology and medicine since its establishment in 1979. With an ISSN of 0325-7541 and an E-ISSN of 1851-7617, this journal has paved the way for disseminating high-quality research while enhancing accessibility for academics and practitioners worldwide. The journal has achieved notable rankings, being classified in Q3 for Medicine (miscellaneous) and Q3 for Medical Microbiology in 2023, reflecting its commitment to advancing knowledge in these critical areas. Despite its relatively modest impact factors, it occupies a vital niche in the academic landscape, fostering collaborations and innovative research among experts. With Open Access available since 2013, REVISTA ARGENTINA DE MICROBIOLOGIA not only facilitates widespread distribution of valuable scientific information but also empowers researchers, professionals, and students to stay abreast of the latest findings and developments in microbiology. For those engaged in the evolving realm of microbiology, this journal serves as an essential resource for sharing insights and advancing the scientific community.